Mangoceuticals, Inc. (NASDAQ:MGRX) Short Interest Down 71.4% in April

Mangoceuticals, Inc. (NASDAQ:MGRX) was the target of a significant decline in short interest in April. As of April 15th, there was short interest totalling 197,600 shares, a decline of 71.4% from the March 31st total of 692,100 shares. Currently, 1.5% of the company’s shares are sold short. Based on an average daily trading volume, of 904,900 shares, the days-to-cover ratio is currently 0.2 days.

Mangoceuticals Trading Up 3.4 %

Shares of NASDAQ MGRX traded up $0.01 during trading on Thursday, reaching $0.28. The stock had a trading volume of 410,119 shares, compared to its average volume of 906,703. Mangoceuticals has a fifty-two week low of $0.14 and a fifty-two week high of $2.38. The business’s 50-day moving average price is $0.22 and its 200-day moving average price is $0.39.

About Mangoceuticals

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It provides erectile dysfunction and hair growth products under the Mango and Mango GROW brand names. The company also offers direct-to-clinics solutions comprising PRIME, an oral testosterone replacement therapy (TRT) prescription product by doctors and medical practitioners to their patients directly from their offices, clinics, and brick and mortar locations.